Mexico Health Summit 2018 Preliminary Speakers
Juana Ramírez is an expert in strategic planning, designing access models, marketing, management of commercial teams, entrepreneurship, leadership and innovation. She is an Endeavor entrepreneur, speaker and mentor in healthcare, entrepreneurship and gender equality. She created the Guerreros contra el cancer (Warriors Against Cancer) foundation, which supports patients and families dealing with this disease. She was named one Mexico’s Top 100 Most Powerful Women by Forbes in 2016.
Alejandro Luna joined Olivares in 1996 and became partner in 2005. He is instrumental in IP, regulatory and administrative litigation. Luna is Co-chair of the Life Sciences & Pharmaceutical Law and Industry Group. He also participated in contesting the constitutionality of certain provisions of the Industrial Property Law and the Federal Copyright Law and sponsored a proposal to modify the litigation and enforcement of IP rights in Mexico. Luna's efforts have helped save the Mexican pharmaceutical industry billions of dollars in protected revenues.
Alejandro Paolini has over 25 years of experience in business management and has worked in Brazil, Venezuela and Argentina. He began his career at Wainstein & Associates, followed by Ernst & Young International and was CEO of Philips Mexico and Director General for healthcare. In his current post, he has led several projects with public and private institutions. Some examples include the digitalization of the imaging department at the National Institute of Cardiology and the installation of the first 64 3-tesla channels at the National Institute of Neurology and Neurosurgery.
Jaime Cervantes has been CEO of Vitalmex since 2007. He has extended professional experience in the health sector and co-founded the Medical-Scientific Committee for the research and development of the first Ventricular Assist Device (VAD) in Latin America. Vitalmex offers services that help improve the quality of life of patients in emerging countries, using innovation and collaboration as guiding principles. His leadership has been fundamental to the company's growth and helped Vitalmex position itself as a leading company in integrated medical solutions. Cervantes has a degree in graphic communication from La Salle University and has multiple studies in marketing, leadership and senior management endorsed by institutions such as IPADE, ITAM and ITESM.
Lizete de la Torre has over 20 years of experience in the pharmaceutical sector working as Market Access Director in Novartis’ Oncology Division and Corporate Affairs and Market Access Director at Bristol-Myers Squibb Mexico. She also worked as Government Sales and Immunology and Central Nervous System Director at Janssen Mexico. She has broad experience in the energy, technology and banking sectors through her work at Intel Corporation, Comisión Nacional Bancaria y de Valores and Tractebel Mexico. De la Torre has a Bachelor’s in International Relations from COLMEX and a Master’s in International Economic Policy from Warwick University.
Monique Clúa is currently the Innovation and Transformation Head for Latin America and Canada at Novartis, in charge of externally revolutionizing the Latin American and Canadian health system commercial models and medical practice towards future needs. Monique Clúa is an executive with more than 16 years of experience in establishing key partnerships, customer engagement and strategic thinking. She is also highly skilled in implementing new business strategies and actions, product launches, communication and negotiations with internal and external stakeholders. Clúa joined Novartis in 2006 and since then she has held roles of increasing responsibility for the company such as Brand Director for Latin America, Specialties Head for Novartis Mexico and Regional Ophthalmology Franchise Head for Novartis LACan.
Antonio Carrasco Ruiz has over 17 years of experience in strategizing and developing innovative products for the telecommunications, editorial, banking and governmental sectors. He has been a speaker and consultant for the World Bank, the Inter-American Development Bank, the US Federal Reserve, Mexico’s Ministry of Foreign Affairs and several government agencies in Mexico and Latin America. Carrasco now leads PLM, heading the company’s digital revolution and aims to consolidate it as a provider of Big Data and AI solutions for healthcare in Mexico and Latin America. He has an MBA from the London School of Economics and a Bachelors’ in Economics from ITESM.
Sandra Sánchez-Oldenhage has 31 years of experience in top-ranked pharmaceutical companies such as Pfizer, MSD, Searle and Pharmacia. She also worked as President and General Manager for Amgen Mexico. In 2014 she joined Probiomed as General Manager and in mid-2018 she joined Biogen as General Manager for Mexico. She established her own consulting firm PharmAdvice to leverage her experience in regulatory and government affairs, access and markets in Mexico.
Joel Cano has 25 years of experience in the commercialization of information and communication technologies and led the launch of a variety of products from Office and MS-DOS 5 to Windows XP in Latin America. Cano was a founding member of Visionaria, the first risk capital and business accelerator focused on technology startups in Latin America. He also created and launched axeleratum.com, an online community of entrepreneurs and SMEs promoted by CONACYT. He has actively participated as an angel investor, entrepreneur and mentor at startups such as Wayra, Startup México and Endeavor in Mexico; Chinaaccelerator in China; Menorca Millennials in Spain and Blockchain Space in the UK.
Juan Manuel Sotelo is an expert in public healthcare committed to equality and development. He is a doctor with over 30 years of experience in international healthcare with PAHO/WHO. Sotelo specializes in building international relationships and organizations and is highly motivated by healthcare and promoting universal access. He has led the Latin American and Caribbean Scientific Information and Healthcare Center and has represented PAHO/WHO in Bolivia, Mexico, Chile and Argentina.
Marco Antonio Navarrete is the Deputy Director of Health Services for PEMEX, the third-largest health institution in Mexico. Over the course of his career, he has held several government positions, including National Coordinator for Subrogated Medical Services and Medical Service Coordinator for the Guadalajara area for PEMEX. Navarrete has taught at several university institutions. He is a surgeon from UNAM and has a specialization in general medicine. Navarrete holds a Master’s in health service administration from Cuauhtemoc University.
Héctor Valle worked for Ciba Geigy, Ciba Vision and Novartis in many leading positions before creating INNOVASALUD. He was also Director General of IMS Health for Mexico, Central America, the Caribbean, Ecuador, Colombia, Peru and Venezuela. Valle has also been member of CANIFARMA, AMIIF, the American Group of Pharmaceutical Laboratories and the Mexican Association of Market Research and Public Opinion Agencies (AMAI). He now teaches Pharmaceutical Direction at ITESM’s Mexico City campus.
Javier Potes is the Founder and Director of Consorcio Mexicano de Hospitales, the largest private hospital group in the country comprising 40 hospitals in 37 cities. He also created SumarSalud, a private healthcare system. Potes is a founding member of the Iberian-Latin American Health League (LILAS) that includes hospital associations from Argentina, Brazil and Colombia. He is now a member of the Directive Council Mexican Foundation for Healthcare (FUNSALUD) and Technical Coordinator at the Health Commission of the Business Coordination Council (CCE).
Antonio Chemor is a biomedical engineer, academic and politician. Prior to his current position he was Finance Director of Seguro Popular, High Specialty Hospitals Coordinator at the State of Mexico and Investment Director and General Planning Development Director for ISSEMyM. At Seguro Popular he has consolidated alliances and agreements to promote health and prevention services though healthy habits and exercise. He is currently a Ph.D. student of Strategic Management and Development Policy at Universidad de Anáhuac.
Efrén Ocampo has over 20 years of experience leading pharmaceutical companies, including Psicofarma, Laboratorios Alpharma, Pego, Prodifam, AB Servicios and Neolpharma. He is also a permanent member of CANIFARMA and a Council Member at ANAFAM. Ocampo has taught several courses at University of Guadalajara, UNAM and Colegio de México and has written several articles related to demographics, population policy and regional development. He led Mexico’s first Population Policy, which won the UN Population Award.
Guillaume Corpart has over 20 years of experience in business consulting. His company, Global Health Intelligence, developed HospiScope, the world’s largest hospital database for Latin America, which profiles over 18,000 hospitals in the region. In 2018, Global Health Intelligence launched SurgiScope to detail procedure volumes by hospital and enable manufacturers to identify targeted
opportunities. In 2011, he was awarded Quebec’s Prix Relève Excellence and in 2014 received the Outstanding Business Award from the Canadian Chamber of Commerce in Mexico.
Roberto Esses has over 10 years of experience in commercial and operative areas from his work in companies such as Red Bull and Coca-Cola. He joined Gympass at the end of December 2017 as head of all commercial areas in Mexico and has recently become the
Country Manager for Gympass Mexico. Esses has a Bachelor’s in Industrial and Systems Engineering from ITESM, an MBA from the University of Texas at Austin and a certificate in Logistics from British Columbia University.
Victor Saadia has held several directorial positions in medical biotechnology companies and is now the Director General of BioCenter México. He is also a part-time professor at ITAM and a speaker at international medical and academic forums. He speaks four languages and has published several research papers in economics, regenerative medicine and science philosophy. Saadia has a Bachelor’s in Economics from ITAM. He is now obtaining a Ph.D. in critical thinking from the European Graduate School in Switzerland..
Xavier Soberón has worked for over 35 years as a researcher in UNAM’s Biotechnology Institute, which he now leads. He has a Ph.D in biomedical research from UNAM and a bachelor’s in Chemistry from Universidad Iberoamericana. He has performed research studies in Los Angeles’ City of Hope Medical Center and California State University. From 1981 he has been heavily involved in the installation and consolidation of UNAM’s departments for genetic engineering, biotechnology and genomics. His research focused on the chemical synthesis of DNA and its applications in the study of proteins and biocatalysts. He has also worked in the development of biopharmaceuticals and vaccines. He won the 1999 National Chemistry Award and has published almost 100 research papers in international journals.
José Campillo has been Technical Secretary of the Exterior Commerce Cabinet of the Presidency of Mexico, a Magistrate at the High Court of Justice, Deputy Minister of Regulation and Health Promotion at the Ministry of Health, Consul General of Mexico in Sacramento, California, and Attorney General of PROFEPA. He has also been Director General of Compañía Minera Cananea and Foreign Commerce Director at Grupo IUSA. In 2003, he founded BL Grupo Consultor, where he was previously President and Director General.
Francisco Kuri has worked in the national and international pharmaceutical industry in different roles, including Researcher at Syntex, Coordinator of the Process Optimization Laboratory at Roche-Syntex, Technical and Regulations Director at Probiomed and New Developments Director at Landsteiner. He is also a coordinator at the Biotechnological Products Committee of the Permanent Commission of Pharmacopoeia in Mexico, expert panel member for the Spanish edition of the US Pharmacopoeia and a committee member at COFEPRIS.
Juan Carlos López is a maxillofacial surgeon with over 25 years of experience and a history of providing altruistic services in Mexico and Palestine. He is the founder of Grupo Impulso, an investor and principal researcher in the mesenchymal field and has given over 60 lectures on stem cells and their relation to regenerative medicine. López has mentored and trained students of maxillofacial surgery and authored many papers. He is coauthoring a book on implantology and bone regeneration and has created a nonprofit association for children with cleft palate.
Alba Tiley is based in the Netherlands at DSM Sinochem Pharmaceuticals. In her role as Head of the Sustainable Antibiotics program she advocates for important sustainability and health topics such as the threat of antimicrobial resistance (AMR). Tiley works on solving strategic issues facing the global community including regulating industrial pollution causing AMR, increasing access to life-saving antibiotics and ensuring their appropriate use. She represents DSP in industry platforms and within multi-stakeholder initiatives such as the platform for sustainable pharmaceutical procurement in the Netherlands. Internally, she drives sustainability throughout the organization by coordinating local sustainability champions and sharing the impact of the global effort across
Yiannis Mallis has worked for Novo Nordisk for over 10 years in strategic and operational roles throughout Latin America, Africa, the Middle East and Europe. His experience includes the development of strategies to improve insulin treatment in the US, Europe, China and Japan, as well as steering investment strategies and analyzing diabetes treatment trends, market and health data. Previously, he led the South American Sub-region based out of Santiago de Chile, which included responsibilities for commercial operations.